Mersana Therapeutics develops antibody drug conjugates for cancer patients with unmet needs. Its products include XMT-1592, XMT-1660, and XMT-2056. The company has partnerships with Merck KGaA and Asana BioSciences for the development of ADC product candidates. Mersana Therapeutics was founded in 2001 and is headquartered in Cambridge, Massachusetts.
Featured Jobs
Related Companies
Other Resources